BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 29, 2003
View Archived Issues
Good efficacy and long-term safety described for MT-100 in migraine
Read More
Commencement of phase II trial of Cop-1 for Huntington's disease
Read More
Guilford awarded grants totaling USD 5.7 million for several programs
Read More
Adolor announces positive results in phase III alvimopan study for postoperative ileus
Read More
Cardioprotective effects described for pexelizumab after acute myocardial infarction
Read More
Gemcabene improves lipid profile of patients with low serum HDL cholesterol levels
Read More
Duloxetine effective in improving anxiety associated with depression
Read More
No adverse effects reported for safinamide after tyramine challenge
Read More
Enhanced activity of novel paclitaxel analogues against drug-resistant breast cancer cells
Read More
Metabotropic glutamate receptor agonist as a nonsedative anxiolytic
Read More
Evaluation of a novel antiestrogen drug delivery system
Read More
FDA grants orphan drug designation for IDN-6556 in liver transplantation
Read More
Lorus and Cyclacel enter license agreement for NC-381
Read More
PhotoCure's Hexvix nearing approval in Europe
Read More
New cannabinoid CB2 ligands prepared and tested at Pharmos
Read More
Na+/H+ exchange inhibitors identified by Aventis researchers
Read More
Nippon Zoki claims novel tachykinin antagonists, their preparation and use
Read More
Novel sodium channel blockers covered by Boehringer Ingelheim patent
Read More
Selective MAO-B inhibitors with utility in Alzheimer's disease and senile dementia
Read More
New neuropeptide Y5 receptor antagonists described by Roche
Read More
Novartis presents new CB1 agonists for pain and other disorders
Read More
Toyama and Eisai submit NDA for antirheumatic drug T-614
Read More
Maxim completes enrollment for phase III trial of Ceplene with IL-2
Read More
Phase III hepatitis C trial of Zadaxin enrolled
Read More
Voltage-gated sodium channel blockers with preference for the inactivated state of the channel
Read More
Dual-target hybrid antibiotics designed at Microbiotix
Read More
OCID-0050, a new investigational oxazolidinone for resistant staphylococcal infections
Read More